Electronegative LDL: a circulating modified LDL with a role in inflammation.

Area of Science:

• Cardiovascular biology
• Lipoprotein research
• Immunology

Background:

• Electronegative low density lipoprotein (LDL(-)) is a minor, modified LDL particle fraction.
• LDL(-) particles share increased electronegativity due to various modifications, including oxidation.
• Oxidized LDL (oxLDL) is known for its inflammatory properties.

Purpose of the Study:

• To investigate the biological effects of electronegative low density lipoprotein (LDL(-)).
• To compare the inflammatory and anti-inflammatory properties of LDL(-) with oxidized LDL (oxLDL).

Main Methods:

• Analysis of LDL particle modification and electronegativity.
• Assessment of inflammatory cytokine release in leukocytes and endothelial cells.
• Evaluation of anti-inflammatory effects on cultured cells.

Main Results:

• LDL(-) demonstrates inflammatory properties, inducing cytokine release in leukocytes and endothelial cells, similar to oxLDL.
• Conversely, LDL(-) also exhibits anti-inflammatory effects on cultured cells.
• These findings highlight a dual biological activity of LDL(-).

Conclusions:

• Electronegative low density lipoprotein (LDL(-)) possesses a dual biological effect, acting as both an inflammatory and anti-inflammatory agent.
• The complex profile of LDL(-) warrants further investigation into its precise role in cardiovascular health and disease.
• Understanding the dual nature of LDL(-) is crucial for developing targeted therapeutic strategies.